metoprolol |
CYP2D6 IM |
4 |
clopidogrel |
1 |
metoprolol |
CYP2D6 IM |
1 |
opioids |
1 |
metoprolol |
CYP2D6 UM |
1 |
clopidogrel |
0 |
atorvastatin |
SLCO1B1 decreased function |
1 |
opioids |
1 |
atorvastatin |
SLCO1B1 decreased function |
3 |
clopidogrel |
1 |
rosuvastatin |
SLCO1B1 decreased function |
1 |
clopidogrel |
0 |
simvastatin |
SLCO1B1 decreased function |
1 |
clopidogrel |
1 |
phenprocoumon |
CYP2C9 NM, CYP4F2 PM, VCORC1 decreased function |
1 |
clopidogrel |
1 |
phenprocoumon |
CYP2C9 NM, CYP4F2 PM, VCORC1 normal function |
1 |
clopidogrel |
1 |
phenprocoumon |
CYP2C9 PM, CYP4F2 NM, VKORC1 decreased function |
1 |
clopidogrel |
1 |
phenprocoumon |
CYP2C9 IM, CYP4F2 IM, VKORC1 decreased function |
2 |
clopidogrel |
1 |
phenprocoumon |
CYP2C9 NM, CYP4F2 NM, VKORC1 decreased function |
1 |
clopidogrel |
1 |
Oxycodon |
CYP2D6 IM |
2 |
clopidogrel |
0 |
Oxycodon |
CYP2D6 IM |
1 |
opioids |
1 |
Oxycodon |
CYP2D6 IM |
1 |
polypsychopharmacotherapy |
0 |
Tramadol |
CYP2D6 IM |
1 |
polypsychopharmacotherapy |
0 |
pantoprazol |
CYP2C19 UM |
1 |
opioids |
1 |
pantoprazol |
CYP2C19 UM |
2 |
clopidogrel |
0 |
tacrolimus |
CYP3A5 expresser |
1 |
opioids |
0 |
flupenthixol |
CYP2D6 IM |
1 |
polypsychopharmacotherapy |
1 |
Sertralin |
CYP2C19 UM |
1 |
polypsychopharmacotherapy |
0 |
Bisoprolol |
CYP2D6 IM |
1 |
screening |
na, PGx
screening |
atorvastatin |
CYP2D6 IM |
1 |
screening |
na, PGx
screening |
amitriptylin |
CYP2D6 PM |
1 |
screening |
na, PGx
screening |